Although IPC confers a highly significant neuroprotection in different in vitro and in vivo models of ischemia, its utilization as a clinical strategy is mostly limited because the onset of retinal ischemia is largely unpredictable, in contrast to the onset of reperfusion that could be more predictable.
1
—
—